The ASCO Annual Meeting is one of the world's largest and most influential oncology conferences, bringing together leading researchers, clinicians, and industry professionals to share the latest advances in cancer research, clinical practice, and innovative therapies. The meeting serves as a premier forum for presenting breakthrough scientific data and fostering collaboration across the global oncology community.

CHOSA participated in ASCO 2026 by presenting two scientific posters, including an ePoster and the poster titled "Combined Gene Signatures Predict Platinum and Taxane Response in the I-SPY2 Breast Cancer Cohort." These presentations highlighted CHOSA's ongoing commitment to advancing precision oncology through the development and validation of predictive biomarkers that support more personalised cancer treatment.

Interested in learning more about our research or discussing collaboration opportunities? Contact us using the button below.